News InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904 Staff September 11, 2023 Continue Reading Previous Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology TherapeuticsNext Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors More Stories Healthcare Hospitals News Nursing Patient Care Redefining the Standard of Care: Introducing the Aulisa® Monitor Camera for Advanced Patient Monitoring Staff November 23, 2024 Apps Financial Fitness News Nutrition Fitness App Market to Expand by USD 55.86 Billion (2024-2028), Driven by Health Management and Rising Chronic Disease Cases, AI Impacting Market Trends – Technavio Staff November 23, 2024 Cancer News Pharmaceutical Vaccine Defence Announces Closing of Securities for Debenture Financing Staff November 22, 2024
